GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis
OSL:GENT - Euronext Oslo - NO0010748866 - Common Stock - Currency: NOK
Overall GENT gets a fundamental rating of 6 out of 10. We evaluated GENT against 53 industry peers in the Health Care Equipment & Supplies industry. GENT has an excellent financial health rating, but there are some minor concerns on its profitability. GENT is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
GENT had positive earnings in the past year.
GENT had a positive operating cash flow in the past year.
GENT had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
1.2 Ratios
GENT has a Return On Assets of 19.72%. This is amongst the best in the industry. GENT outperforms 96.23% of its industry peers.
GENT's Return On Equity of 23.34% is amongst the best of the industry. GENT outperforms 88.68% of its industry peers.
GENT has a Return On Invested Capital of 6.07%. This is in the better half of the industry: GENT outperforms 66.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 19.72% | ||
| ROE | 23.34% | ||
| ROIC | 6.07% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 29.78%, GENT belongs to the top of the industry, outperforming 96.23% of the companies in the same industry.
GENT has a better Operating Margin (10.34%) than 66.04% of its industry peers.
The Gross Margin of GENT (54.46%) is comparable to the rest of the industry.
GENT's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.34% | ||
| PM (TTM) | 29.78% | ||
| GM | 54.46% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GENT is destroying value.
Compared to 1 year ago, GENT has about the same amount of shares outstanding.
GENT has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, GENT has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 13.80 indicates that GENT is not in any danger for bankruptcy at the moment.
GENT has a better Altman-Z score (13.80) than 100.00% of its industry peers.
GENT has a debt to FCF ratio of 2.20. This is a good value and a sign of high solvency as GENT would need 2.20 years to pay back of all of its debts.
The Debt to FCF ratio of GENT (2.20) is better than 84.91% of its industry peers.
GENT has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.03, GENT belongs to the best of the industry, outperforming 96.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 2.2 | ||
| Altman-Z | 13.8 |
ROIC/WACC0.71
WACC8.59%
2.3 Liquidity
GENT has a Current Ratio of 5.38. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
GENT has a better Current ratio (5.38) than 98.11% of its industry peers.
GENT has a Quick Ratio of 3.85. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
GENT has a Quick ratio of 3.85. This is amongst the best in the industry. GENT outperforms 92.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.38 | ||
| Quick Ratio | 3.85 |
3. Growth
3.1 Past
GENT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 522.84%, which is quite impressive.
GENT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.52%.
GENT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.96% yearly.
EPS 1Y (TTM)522.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%422.94%
Revenue 1Y (TTM)12.52%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.73%
3.2 Future
GENT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 58.89% yearly.
Based on estimates for the next years, GENT will show a very strong growth in Revenue. The Revenue will grow by 31.47% on average per year.
EPS Next Y76.24%
EPS Next 2Y58.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year33.11%
Revenue Next 2Y31.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
GENT is valuated rather expensively with a Price/Earnings ratio of 17.27.
Compared to the rest of the industry, the Price/Earnings ratio of GENT indicates a somewhat cheap valuation: GENT is cheaper than 79.25% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.18. GENT is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 27.48 indicates a quite expensive valuation of GENT.
The rest of the industry has a similar Price/Forward Earnings ratio as GENT.
When comparing the Price/Forward Earnings ratio of GENT to the average of the S&P500 Index (20.81), we can say GENT is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.27 | ||
| Fwd PE | 27.48 |
4.2 Price Multiples
GENT's Enterprise Value to EBITDA is on the same level as the industry average.
GENT's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 306.92 | ||
| EV/EBITDA | 27.96 |
4.3 Compensation for Growth
GENT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GENT's earnings are expected to grow with 58.89% in the coming years.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y58.89%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a yearly dividend of 0.85%, GENT is not a good candidate for dividend investing.
GENT's Dividend Yield is a higher than the industry average which is at 2.47.
With a Dividend Yield of 0.85, GENT pays less dividend than the S&P500 average, which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.85% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y58.89%
EPS Next 3YN/A
OSL:GENT (5/2/2025, 7:00:00 PM)
49.9
+2.9 (+6.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners30.99%
Inst Owner ChangeN/A
Ins Owners2.59%
Ins Owner ChangeN/A
Market Cap769.46M
Analysts85.71
Price Target68.34 (36.95%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.85% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)18.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.27 | ||
| Fwd PE | 27.48 | ||
| P/S | 5.06 | ||
| P/FCF | 306.92 | ||
| P/OCF | 57.18 | ||
| P/B | 3.97 | ||
| P/tB | 4.65 | ||
| EV/EBITDA | 27.96 |
EPS(TTM)2.89
EY5.79%
EPS(NY)1.82
Fwd EY3.64%
FCF(TTM)0.16
FCFY0.33%
OCF(TTM)0.87
OCFY1.75%
SpS9.86
BVpS12.58
TBVpS10.74
PEG (NY)0.23
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 19.72% | ||
| ROE | 23.34% | ||
| ROCE | 7.88% | ||
| ROIC | 6.07% | ||
| ROICexc | 10.54% | ||
| ROICexgc | 14.02% | ||
| OM | 10.34% | ||
| PM (TTM) | 29.78% | ||
| GM | 54.46% | ||
| FCFM | 1.65% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 2.2 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 122.17% | ||
| Cap/Sales | 7.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 54.51% | ||
| Profit Quality | 5.54% | ||
| Current Ratio | 5.38 | ||
| Quick Ratio | 3.85 | ||
| Altman-Z | 13.8 |
F-Score5
WACC8.59%
ROIC/WACC0.71
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)522.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%422.94%
EPS Next Y76.24%
EPS Next 2Y58.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.52%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.73%
Revenue Next Year33.11%
Revenue Next 2Y31.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y318.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year184.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-77.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.94%
OCF growth 3YN/A
OCF growth 5YN/A